Updated Jul 16, 2026
Lesage Anne has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.76M.
Anne Lesage is associated with Pharvaris N.V., a biopharmaceutical company focused on developing treatments for hereditary angioedema. Specific details about her role and contributions are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 30.7K | $35.49 | $1.09M |
| 2026-07-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 7.0K | $35.05 | $245K |
| 2026-07-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 27.9K | $35.48 | $989K |
| 2026-07-01 | PHVS | Pharvaris N.V. | M — Option exercise | 24.9K | $8.05 | $200K |
| 2026-07-01 | PHVS | Pharvaris N.V. | M — Option exercise | 3.0K | $2.59 | $8K |
| 2026-07-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 8.3K | $35.05 | $291K |
| 2026-07-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 2.3K | $35.12 | $81K |
| 2026-07-01 | PHVS | Pharvaris N.V. | M — Option exercise | 4.2K | $8.05 | $34K |
| 2026-07-01 | PHVS | Pharvaris N.V. | M — Option exercise | 4.1K | $2.59 | $11K |
| 2026-07-01 | PHVS | Pharvaris N.V. | M — Option exercise | 900 | $8.05 | $7K |
| 2026-07-01 | PHVS | Pharvaris N.V. | M — Option exercise | 1.4K | $2.59 | $4K |
| 2026-06-29 | PHVS | Pharvaris N.V. | S — Open-market sale | 2.3K | $35.12 | $81K |
| 2026-06-29 | PHVS | Pharvaris N.V. | S — Open-market sale | 2.3K | $35.12 | $81K |
| 2026-06-29 | PHVS | Pharvaris N.V. | M — Option exercise | 900 | $8.05 | $7K |
| 2026-06-29 | PHVS | Pharvaris N.V. | M — Option exercise | 1.4K | $2.59 | $4K |
| 2026-05-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 19.2K | $30.26 | $581K |
| 2026-05-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 3.7K | $30.06 | $111K |
| 2026-05-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 18.0K | $30.26 | $545K |
| 2026-05-01 | PHVS | Pharvaris N.V. | M — Option exercise | 18.0K | $8.05 | $145K |
| 2026-05-01 | PHVS | Pharvaris N.V. | S — Open-market sale | 3.7K | $30.26 | $112K |
Anne Lesage is associated with Pharvaris N.V., a biopharmaceutical company focused on developing treatments for hereditary angioedema. Specific details about her role and contributions are not widely documented.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 17 open-market sales ($4.76M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lesage Anne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.